| Patents for C07C 225 - Compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly-bound oxygen atoms not being part of a cho group, e.g. amino ketones (4,302) |
|---|
| 11/19/2002 | CA2115143C Macromonomers having reactive end groups |
| 11/19/2002 | CA2038934C Anti-cancer compounds |
| 11/14/2002 | US20020169192 Peroxisome proliferator activator receptor (PPAR); amino-ethyl- phenyl derivatives |
| 11/14/2002 | US20020166180 For oxidative coloring agent for keratin fibers |
| 11/13/2002 | EP1140200B1 Anthraquinone anticancer drugs |
| 11/13/2002 | CN1379755A Substituted 2-dialkylamino alkylbiphenyl derivatives |
| 11/12/2002 | US6479706 Aminobenzophenones and photopolymerizable compositions including the same |
| 11/12/2002 | US6479554 Immunotherapeutic agents |
| 11/12/2002 | US6479552 Use of substituted N, N-disubstituted diamino compounds for inhibiting cholesteryl ester transfer protein activity |
| 11/07/2002 | WO2001047866A9 Substituted 1 and 2 naphthol mannich bases |
| 11/07/2002 | WO2001042243A3 Protein kinase inhibitors |
| 11/07/2002 | US20020165232 Substituted N, N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 11/07/2002 | US20020165231 Substituted N-heteroaryl-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 11/06/2002 | EP1254892A2 N-substituted-aminomethyl cyclopropyl ketone derivatives or salts thereof and production process therefor |
| 11/06/2002 | EP1254883A1 Process for producing sobstituted 1,1,1-trifluoro-3-butene-2-ones |
| 11/05/2002 | US6476075 Use of substituted N, N-bis-benzyl aminoalcohol compounds inhibiting cholesteryl ester transfer protein activity |
| 11/05/2002 | US6476057 Use of substituted N, N-disubstituted cycloalkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity |
| 10/31/2002 | WO2001070675A3 Inhibitors of histone deacetylase |
| 10/31/2002 | US20020161262 Use treating various medical conditions, including pain |
| 10/24/2002 | WO2002083624A1 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 10/24/2002 | WO2002002516A3 Inhibitors of hiv integrase |
| 10/24/2002 | WO2001098265B1 Process for isolating enantiomers of racemic cetamine |
| 10/24/2002 | US20020156325 Reacting a beta-yne-one with a primary or secondary amine; used in chemical vapor deposition |
| 10/24/2002 | US20020156323 N-substituted-aminomethyl cyclopropyl ketone derivatives or salts thereof and production process therefor |
| 10/24/2002 | US20020156295 Coordination catalyst containing ligand |
| 10/23/2002 | EP1064243B1 Coupling reactions with palladium catalysts |
| 10/22/2002 | US6468753 Anthraquinone and its derivatives |
| 10/17/2002 | WO2002081483A2 Inhibitors of acyl glucosaminyl inositol amidase and methods of use |
| 10/17/2002 | DE10114970A1 New 1,2-diamino-4-azolyl-, -4-furyl-, -4-thienyl-, -4-phenyl- and -4-azinyl-benzene compounds and known analogues are used in oxidative colorants for keratin fibers, especially human hair |
| 10/17/2002 | DE10104770C1 (1,1'-Biphenyl)-2,4-diamin-Derivate enthaltende Färbemittel für Keratinfasern sowie neue (1,1'-Biphenyl)-2,4-diamin-Derivate (1,1'-biphenyl) -2,4-diamine derivatives containing a colorant for keratin fibers and new (1,1'-biphenyl) -2,4-diamine derivatives |
| 10/16/2002 | CN1374288A Gronwell naphthaquinone derivative and its application in preparing anticancer medicine |
| 10/15/2002 | US6465523 4-substituted-3-substituted-amino-cyclobut-3-ene-1,2-diones and analogs thereof as novel potassium channel openers |
| 10/15/2002 | US6465522 Anthraquinone anticancer drugs |
| 10/10/2002 | WO2002078693A2 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor |
| 10/10/2002 | US20020147336 Glucocorticoid receptor modulators |
| 10/09/2002 | EP1246791A2 Aminomethyl-phenyl-cyclohexanone derivatives |
| 10/09/2002 | EP1246790A1 Substituted 1 and 2 naphthol mannich bases |
| 10/09/2002 | CN1373745A 3-amino-2-benzyl-1-phenyl-propane derivs. |
| 10/08/2002 | US6462092 Such as 3-((3-fluorophenyl)-((3-(trifluoromethyl)phenyl)-methyl)amino)-1,1,1 -trifluoro-2-propanol; cardiovascular disease, i.e. atherosclerosis and other coronary artery diseases |
| 10/08/2002 | US6462059 Treatment of disorders associated with smooth muscle contraction; urinary incontinence, asthma, premature labor, irritable bowel syndrome, congestive heart failure, angina, and cerebral vascular disease |
| 10/03/2002 | WO2002076995A2 2-amino-propanol derivatives |
| 10/03/2002 | WO2002076939A2 Cysteine protease inhibitors |
| 10/03/2002 | WO2002076926A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists |
| 10/03/2002 | WO2002076447A1 Hallogenated aminobenzophenones and aminobenzoylpyridines as inhibitors of il-1 and tnf |
| 10/03/2002 | CA2442178A1 2-amino-propanol derivatives |
| 10/03/2002 | CA2436351A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists |
| 10/02/2002 | EP1244624A1 Anthracene derivatives as anti-cancer agents |
| 10/02/2002 | CN1091594C Use of anti-viral compound in preparing medicine for curing virus infection |
| 10/01/2002 | US6458852 Use of substituted N, N-bis-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity |
| 10/01/2002 | US6458849 Method of treating or preventing a ceip-mediated disorder in a subject by administering a therapeutically effective amount of a compound for strokes |
| 10/01/2002 | US6458803 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity |
| 09/26/2002 | US20020137969 Novel arylamine compound and organic electroluminescence device |
| 09/25/2002 | EP1242379A1 Curcumin analogues for treating cancer |
| 09/25/2002 | EP1242363A2 Cd45 inhibitors |
| 09/25/2002 | CN1371359A Aminobenzophenones as inhibitors IL-1 beta and TNF-alpha |
| 09/24/2002 | US6455519 Use of substituted N, N-disubstituted fused-heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity |
| 09/19/2002 | WO2002072620A1 Tumour targeting prodrugs activated by metallo matrixproteinases |
| 09/19/2002 | WO2002058630A3 Primary intermediate for oxidative coloration of hair |
| 09/19/2002 | US20020132852 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use |
| 09/19/2002 | CA2440208A1 Tumour targeting prodrugs activated by metallo matrixproteinases |
| 09/18/2002 | EP1117633B1 Diaminocyclobutene-3,4-dione derivatives, their preparation and use |
| 09/18/2002 | EP0984921B1 Process for the preparation of substituted keto-enamines |
| 09/17/2002 | US6451940 Catalysts for olefin polymerizations |
| 09/17/2002 | US6451830 Use of substituted N,N-disubstituted non-fused heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity |
| 09/17/2002 | US6451823 Use of substituted N-phenoxy-N-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity |
| 09/11/2002 | EP1237951A1 Catalysts for olefin polymerizations |
| 09/11/2002 | EP1237845A1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 09/11/2002 | CN1368953A Aminobenzophenones as inhibitors of IL-1 bata and TNF-alpha |
| 09/11/2002 | CN1368950A Novel aminobenzophenones |
| 09/10/2002 | US6448295 Treating cardiovascular disease; atherosclerosis, dyslipidema hypercholesterolaemia; decreasing concentrations of low density lipoprotein and raising level of high density lipoprotein |
| 09/05/2002 | US20020123652 2-aminotetralines and pharmaceutical compositions for the prevention and therapeutic treatment of inflammatory and/or autoimmune pathologies |
| 09/04/2002 | CN1367781A Method for preparing 2-(2-arylmorpholin-2-Yl) ethanol derivatives and intermediates |
| 09/04/2002 | CN1090020C 4,4-(disubstituted) cyclohexan-1-ols and related compounds |
| 09/04/2002 | CN1090019C 组合物 The composition |
| 09/03/2002 | US6444606 Supported catalyst system, method for the production and use thereof in olefin polymerization |
| 08/29/2002 | WO2002066416A1 Method of synthesizing camptothecin-relating compounds |
| 08/29/2002 | US20020120011 Substituted N, N-disubstituted diamino compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 08/29/2002 | CA2683768A1 Method of synthesizing camptothecin-relating compounds |
| 08/27/2002 | US6441177 (4-bromo-phenyl)-(4-(6-(cyclopropyl-methyl-amino)-hexyloxy)-2-fluoro -phenyl)-methanone; antimycotic and cholesterol lowering activity |
| 08/22/2002 | WO2002064136A2 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 08/22/2002 | WO2002064130A1 Proliferative activator receptor (ppar) compounds |
| 08/22/2002 | US20020115826 Enzyme inhibitor for use for use in the treatment of cell proliferative defects |
| 08/22/2002 | CA2438492A1 Proliferative activator receptor (ppar) compounds |
| 08/21/2002 | EP0971924B1 Photoactivatable nitrogen-containing bases based on alpha-amino ketones |
| 08/20/2002 | US6437149 Cationic aminoanthraquinones, their use for dyeing keratinous fibers, dyeing compositions containing them and methods of dyeing |
| 08/20/2002 | CA2291072C Method for the preparation of citalopram |
| 08/15/2002 | WO2002062307A1 Colouring agents for keratin fibres containing (1.1'-biphenyl)-2.4-diamine derivatives in addition to novel (1.1'-biphenyl)-2.4-diamine-derivatives |
| 08/15/2002 | WO2001098265A3 Process for isolating enantiomers of racemic cetamine |
| 08/15/2002 | US20020111347 Nervous system disorders |
| 08/15/2002 | CA2436432A1 Colouring agents for keratin fibers containing (1,1'-biphenyl)-2,4-diamine derivatives in addition to novel (1,1'-biphenyl)-2,4-diamine-derivatives |
| 08/07/2002 | EP1229019A1 Process for the production of optically active cyclic enaminone derivatives |
| 08/06/2002 | US6428912 Electron transport material and light emitting diode that contains the electron transport material |
| 08/01/2002 | WO2002058630A2 Primary intermediate for oxidative coloration of hair |
| 08/01/2002 | CA2431631A1 Primary intermediate for oxidative coloration of hair |
| 07/31/2002 | EP1227079A2 Asymmetric beta-ketoiminate ligand compound, preparation method thereof and organometal percursor comprising the same |
| 07/31/2002 | EP1042310B1 Method for the preparation of citalopram |
| 07/31/2002 | CN1361763A Aminobenzophenones as inhibitors of IL-1 beta and TNF_alpha |
| 07/25/2002 | WO2002057211A1 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (adp-ribose) glycohydrolase, and methods for their use |
| 07/25/2002 | WO2002057199A1 Process for a homogeneously catalyzed c-c coupling reaction |
| 07/25/2002 | WO2001040188A9 Curcumin analogues for treating cancer |